China Diagnostic Imaging Equipment Market Industry Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

China's diagnostic imaging equipment market comprises medical imaging systems, including computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, and nuclear medicine equipment, installed in hospitals, specialty clinics, and diagnostic centers throughout the country. The market is valued at approximately $3.28 billion in 2025 and is projected to grow at a 6.11 percent annual rate. While government statistical agencies publish general healthcare expenditure data and regulatory filings, specific diagnostic imaging equipment market figures are derived from commercial industry analysts based on manufacturer shipments, import-export records, and healthcare facility procurement patterns.

• •Market size of $3.28 billion in 2025 with a 6.11 percent compound annual growth rate
• •Official government statistical agencies do not publish standalone diagnostic imaging market size figures; data relies on commercial analyst estimates
• •Broader China medical devices market estimated at approximately $43 billion in 2025, with diagnostic imaging representing a significant and growing portion

China's aging demographic profile is a fundamental driver of diagnostic imaging demand, as older populations require more frequent and advanced imaging procedures for chronic disease management. Rising incomes and expanding health insurance coverage have increased patient access to advanced imaging services, while the government's Healthy China 2030 initiative emphasizes modernizing hospital infrastructure. Government policies promoting domestic device manufacturing have reduced import dependence and accelerated the adoption of locally produced imaging equipment.

• •Aging population and increasing prevalence of lifestyle-related chronic diseases such as cancer, cardiovascular conditions, and respiratory disorders drive higher imaging volumes
• •Government localization policies and manufacturing incentive programs encourage domestic production and procurement of Chinese-made imaging equipment
• •Continued hospital infrastructure expansion and tier-2 and tier-3 city healthcare access improvement programs increase equipment installation rates

The market spans multiple imaging modalities, including CT scanners, MRI systems, general X-ray and fluoroscopy, ultrasound, and nuclear medicine equipment such as PET and SPECT systems. Modality segments vary in growth rate, with nuclear medicine imaging among the fastest-expanding categories. Geographically, demand concentrates in coastal provinces and major metropolitan areas with higher hospital density and healthcare budgets, though tier-2 and tier-3 cities represent the fastest-growing deployment regions as healthcare networks expand inland.

• •Nuclear medicine imaging segment growing at approximately 17.9 percent annually, significantly outpacing overall market growth
• •Coastal regions and tier-1 cities currently dominate market share, while tier-2 and tier-3 cities represent the highest growth opportunity
• •Modality mix shifting toward advanced imaging such as 3T MRI, high-end CT, and molecular imaging as hospital capabilities advance

What are the recent trends and outlook?

The market outlook anticipates continued growth supported by ongoing healthcare reforms, equipment replacement cycles, and sustained government emphasis on domestic manufacturing and innovation. Imaging equipment with artificial intelligence-enabled image analysis, cloud-connected platforms, and improved workflow integration is increasingly valued by hospitals seeking operational efficiency. Long-term projections suggest China will remain the dominant national market in the Asia-Pacific diagnostic imaging equipment sector and a key contributor to global market growth through 2031 and beyond.

• •Artificial intelligence integration in imaging systems for automated image interpretation and workflow optimization is becoming a competitive differentiator
• •Government-driven localization targets continue to favor domestic manufacturers in public hospital procurement tenders
• •Asia-Pacific region identified as a primary global growth driver for diagnostic imaging equipment, with China as the leading contributor